Showing results (201-210 of 384) with videos related to

Sort By:
Pageof 39
Cancers|March 13, 2024
Efficacy and Safety of Ripretinib in Advanced Gastrointestinal Stromal Tumors within an Expanded Access Program: A Cohort StudySu Yin Lim, Laura Ferro-López, Elizabeth Barquin, et al.
Cancer Research|January 7, 2006
Noninvasive magnetic resonance spectroscopic pharmacodynamic markers of the choline kinase inhibitor MN58b in human carcinoma modelsNada M S Al-Saffar, Helen Troy, Ana Ramírez de Molina, et al.
Cancer Chemotherapy and Pharmacology|August 19, 2015
A phase I open-label trial evaluating the cardiovascular safety of regorafenib in patients with advanced cancerRobin L Jones, Johanna C Bendell, David C Smith, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 21, 2006
Distribution and significance of nerve growth factor receptor (NGFR/p75NTR) in normal, benign and malignant breast tissueJorge S Reis-Filho, Dawn Steele, Silvana Di Palma, et al.
ESMO Open|July 19, 2018
2018 ESMO Sarcoma and GIST Symposium: 'take-home messages' in soft tissue sarcomaAnna Maria Frezza, Alex T J Lee, Eran Nizri, et al.
British Journal of Cancer|September 8, 2023
Axitinib in patients with advanced/metastatic soft tissue sarcoma (Axi-STS): an open-label, multicentre, phase II trial in four histological strataPenella J Woll, Piers Gaunt, Charlotte Gaskell, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|September 27, 2014
Analysis of clinical prognostic factors for adult patients with head and neck sarcomasAmy E Chang, Xiaoyu Chai, Seth M Pollack, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 27, 2024
Best Overall Response-Associated Signature to Doxorubicin in Soft Tissue Sarcomas: A Transcriptomic Analysis from ANNOUNCEJiangang Liu, David S Moura, Robin L Jones, et al.
Journal of Geriatric Oncology|May 26, 2019
Subgroup analysis of older patients treated within the randomized phase 3 doxorubicin versus doxorubicin plus evofosfamide (SARC021) trialEugenie Younger, Karla Ballman, Yao Lu, et al.
Gynecologic Oncology|September 16, 2011
Trabectedin in advanced uterine leiomyosarcomas: a retrospective case series analysis from two reference centersRoberta Sanfilippo, Federica Grosso, Robin L Jones, et al.
Pageof 39